BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21496876)

  • 1. Replication protein A: a reliable biologic marker of prognostic and therapeutic value in human astrocytic tumors.
    Kanakis D; Levidou G; Gakiopoulou H; Eftichiadis C; Thymara I; Fragkou P; Trigka EA; Boviatsis E; Patsouris E; Korkolopoulou P
    Hum Pathol; 2011 Oct; 42(10):1545-53. PubMed ID: 21496876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
    Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
    Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
    Korkolopoulou P; Levidou G; Saetta AA; El-Habr E; Eftichiadis C; Demenagas P; Thymara I; Xiromeritis K; Boviatsis E; Thomas-Tsagli E; Panayotidis I; Patsouris E
    Hum Pathol; 2008 Aug; 39(8):1143-52. PubMed ID: 18495209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin D2 is an independent predictor of the development of hepatic metastasis in colorectal cancer.
    Sarkar R; Hunter IA; Rajaganeshan R; Perry SL; Guillou P; Jayne DG
    Colorectal Dis; 2010 Apr; 12(4):316-23. PubMed ID: 19508551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
    Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors.
    Draper N; Bui M; Boulware DC; Lloyd M; Chiappori AA; Pledger WJ; Coppola D
    Hum Pathol; 2008 Dec; 39(12):1784-91. PubMed ID: 18701138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D3 expression in primary Ta/T1 bladder cancer.
    Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
    J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication protein A in nonearly ovarian adenocarcinomas: correlation with MCM-2, MCM-5, Ki-67 index and prognostic significance.
    Levidou G; Ventouri K; Nonni A; Gakiopoulou H; Bamias A; Sotiropoulou M; Papaspirou I; Dimopoulos MA; Patsouris E; Korkolopoulou P
    Int J Gynecol Pathol; 2012 Jul; 31(4):319-27. PubMed ID: 22653344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
    Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
    Hara A; Saegusa M; Ichinoe M; Okayasu I
    J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin genes in human gastric cancer and in first degree relatives.
    Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
    Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.